Stockreport

Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit

Vaxcyte, Inc.  (PCVX) 
PDF SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company managemen [Read more]